Search: Clinical Trials & Medical Discoveries Headlines from PR Newswire < Go Back Boston Scientific Reports Lotus™ Valve System Met Primary Performance Endpoint in REPRISE II Trial Wed May 22 2013, 10:41 ET Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance Wed May 22 2013, 9:43 ET Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures Wed May 22 2013, 9:30 ET Boston Scientific Promus PREMIER™ And SYNERGY™ Drug-Eluting Stent Systems Provide Exceptional Safety And Efficacy Data Wed May 22 2013, 9:13 ET Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency Wed May 22 2013, 8:47 ET Cellular Biomedicine Group Announces Enrollment Milestone for Phase I Clinical Trial for Liver Cancer Wed May 22 2013, 8:01 ET Ambit Biosciences Announces Presentations of Data from Clinical Investigations of Quizartinib at the Annual Meeting of the American Society of Clinical Oncology Wed May 22 2013, 8:00 ET Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye Wed May 22 2013, 7:30 ET iBio Technology Produces Vaccine Candidate for Recently Emerged H7N9 Influenza Wed May 22 2013, 7:30 ET Oncolytics Biotech® Inc. Meets Primary Endpoint for First Stage of U.S. Phase 2 Metastatic Melanoma Trial Wed May 22 2013, 6:30 ET OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting Wed May 22 2013, 6:30 ET Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Wed May 22 2013, 2:00 ET New Data Show Long-Term Benefit of Transcranial Magnetic Stimulation in Difficult-to-Treat Patients with Depression using NeuroStar TMS Therapy System Tue May 21 2013, 17:00 ET Changing Cancer's Environment To Halt Its Spread Tue May 21 2013, 16:25 ET LipiGesic® M Migraine Treatment Product Shown to be as Effective as Prescription Based Medications Tue May 21 2013, 14:33 ET Study Finds Vitamin C Can Kill Drug-Resistant TB Tue May 21 2013, 12:35 ET Boston Scientific Long Term Data Demonstrate Bronchial Thermoplasty Treatment Benefits Persist Out to Five Years in Patients with Severe Asthma Tue May 21 2013, 11:46 ET ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials Tue May 21 2013, 10:00 ET Maryland Stem Cell Research Commission Funds 31 New Research Proposals in FY 2013 Tue May 21 2013, 9:00 ET New Data Validates CyberKnife SBRT for Prostate Cancer Treatment Tue May 21 2013, 8:30 ET Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients Tue May 21 2013, 8:15 ET Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine Tue May 21 2013, 8:15 ET Boehringer Ingelheim Presents Phase 3 Sub-Analyses for Tiotropium Across a Range of Symptomatic Asthma Patients at ATS 2013 Tue May 21 2013, 8:15 ET New Colonoscope Provides Ground-Breaking View Of Colon Tue May 21 2013, 8:00 ET Benvenue Medical Completes Follow-Up Phase in KAST Study Evaluating Kiva® VCF Treatment System vs. Balloon Kyphoplasty Tue May 21 2013, 8:00 ET Coffee Consumption Associated With Reduced Risk Of Autoimmune Liver Disease Tue May 21 2013, 8:00 ET Vitamin D Supplements May Help Relieve Symptoms Related To Crohn's Tue May 21 2013, 8:00 ET Oncopeptides Secures Venture Funding for Phase II Trial of Melflufen in Multiple Myeloma Patients Tue May 21 2013, 8:00 ET Echo Therapeutics Announces Institutional Review Board (IRB) Approval for Its Clinical Trial of the Symphony® CGM System Tue May 21 2013, 7:50 ET Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain Tue May 21 2013, 7:30 ET Complix to Present at Upcoming BioEquity Europe 2013 Tue May 21 2013, 7:18 ET Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study Tue May 21 2013, 7:00 ET MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer Tue May 21 2013, 7:00 ET Verrata™ Pressure Guide Wire and iFR® (Instant Wave-Free Ratio™) Software Modality will be on display at EuroPCR 2013[1] Tue May 21 2013, 4:40 ET Industry insists Australian clinical trials are internationally cost competitive contrary to 2012 report Mon May 20 2013, 21:50 ET Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) Mon May 20 2013, 17:00 ET Pacific Shore Holdings Retains Investor Relations Firm Mon May 20 2013, 14:09 ET New Study Identifies the Optimal Dose of Intravenous Vitamin C for Future Anticancer Clinical Trials Mon May 20 2013, 11:26 ET The WIRB-Copernicus Group Partners with Mytrus, Inc. to Deliver Revolutionary, Interactive Electronic Informed Consent Solution Mon May 20 2013, 11:23 ET For Chronic Obstructive Pulmonary Disease, Surveyed Pulmonologists Indicate That Improved Effect on Quality of Life is One of the Greatest Unmet Needs Mon May 20 2013, 10:56 ET AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy Mon May 20 2013, 10:45 ET Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania Mon May 20 2013, 9:15 ET Rhythm Announces Phase 1b Results for Ghrelin Prokinetic RM-131 for Gastroparesis in Patients with Type 1 Diabetes Mon May 20 2013, 8:30 ET CardioDx Announces Publication of the IMPACT-CARD Trial Demonstrating Use of Corus® CAD Test Influenced Cardiologists' Clinical Management of Patients with Symptoms Suggestive of Obstructive Coronary Artery Disease Mon May 20 2013, 8:30 ET Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes Mon May 20 2013, 8:00 ET Cempra Presents Post-Phase 2 Analysis of Solithromycin's Efficacy and Safety Results from Patients with Community Acquired Bacterial Pneumonia (CABP) Mon May 20 2013, 8:00 ET Sports Medicine New Frontiers: Platelet-Rich-Plasma (PRP) and Stem Cell Therapy Mon May 20 2013, 8:00 ET TRACON Pharmaceuticals Announces TRC105 Clinical Trials, Abstract Presentations at 2013 ASCO Annual Meeting Mon May 20 2013, 8:00 ET Intercept Pharmaceuticals Announces Positive Initial Results from Ongoing Phase 2a Trial in Chronic Bile Acid Diarrhea Mon May 20 2013, 8:00 ET New Study Shows Effects of Medicinal Mushroom Extract on Pancreatic Cancer Cells Mon May 20 2013, 7:00 ET < Prev Next >